The highway to a candidate antibody

An integrated platform for target/antibody validation

A unique environment for the development of immunotherapies in cancer and inflammation.

Event

From 2019-03-28 to 2019-03-28

MI-mAbs has partnered with Eurobiomed for this one-day symposium on immunotherapy antibodies and cellular therapies

Outsourcing R&D

Using syngeneic mouse models

Making the right Ab format

ADCC & ADCC-like assays

Milligram to gram scale production

First model to validate bispecifics

Site-specific conjugation

The French demonstrator of immunotherapy antibodies